No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
VKTX241227P44000
- 2.55
- -1.20-32.00%
15min DelayClose Dec 20 16:00 ET
2.55High1.55Low
1.98Open3.75Pre Close16 Volume58 Open Interest44.00Strike Price2.83KTurnover141.93%IV1.89%PremiumDec 27, 2024Expiry Date1.75Intrinsic Value100Multiplier4DDays to Expiry0.80Extrinsic Value100Contract SizeAmericanOptions Type-0.5702Delta0.0592Gamma11.58Leverage Ratio-0.3055Theta-0.0032Rho-6.60Eff Leverage0.0184Vega
Intraday
- 5D
- Daily
News
Why Viking Therapeutics Tumbled by More Than 10% This Week
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla -- WSJ
B.Riley Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $109
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125
B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)